Infrastructure Capital Advisors »

Halozyme Therapeutics shares owned by Infrastructure Capital Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Infrastructure Capital Advisors from 13F filings

Historical chart of Infrastructure Capital Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Infrastructure Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Infrastructure Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $491k 7.3k 67.30
2024-03-31 $331k 8.1k 40.68
2023-12-31 $517k 14k 36.96

More positions owned by Infrastructure Capital Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apollo Global Mgmt Ser A Mand Cnv (APO.PA)
Kkr & Co 6.25 Con Ser D (KKR.PD)
MPLX Com Unit Rep Ltd (MPLX)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Energy Transfer Com Ut Ltd Ptn (ET)
Hess Midstream Cl A Shs (HESM)
Western Midstream Partners L Com Unit Lp Int (WES)
Rlj Lodging Tr Cum Conv Pfd A (RLJ.PA)
Enterprise Products Partners (EPD)
Flagstar Bank National Assoc Unit 05/07/2051 (FLG.PU)
Sunoco Lp/sunoco Fin Corp Com Ut Rep Lp (SUN)
Boeing Dep Conv Pfd A (BA.PA)
Cheniere Energy Com New (LNG)
Ares Management Corporation 6.75 Se B Pfd (ARES.PB)

View all positions for Infrastructure Capital Advisors

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Alliancebernstein
Norges Bank Investment Management
William Blair Investment Management
Federated Investors
Jupiter Asset Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics